敏芯股份(688286.SH)收到《無效宣告請求審查決定書》
格隆匯10月13日丨敏芯股份(688286.SH)公佈,公司於近日收到了專利代理機構轉來的國家知識產權局出具的《無效宣告請求審查決定書》。國家知識產權局專利局複審和無效審理部對無效宣告請求人王莉提出的公司擁有的“微硅麥克風及其製作方法”專利權之無效宣告請求進行了審查,決定宣告專利權全部無效。
本次無效宣告請求審查決定涉及的發明專利被宣告全部無效後,公司和同行業其他公司均可以合法、無償地使用上述發明專利。公司的核心競爭力來自於包括基礎技術、技術訣竅、專利等構成的多層次核心技術體系,依靠產品更新迭代能力而非專利優勢搶佔市場,僅專利被無效並不影響公司核心技術體系整體,亦不會對公司未來日常生產經營產生重大不利影響,公司可以繼續使用上述專利對應的相關技術。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.